Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Similar documents
AF ABLATION Concepts and Techniques

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Long Standing Persistent AF ; CPVI is enough for it

What s new in my specialty?

Debate-STAR AF 2 study. PVI is not enough

Radiofrequency Catheter Ablation for Atrial Fibrillation

Ablation of persistent AF Is it different than paroxysmal?

Individualised strategy approach to AF ablation

CATHETER ABLATION FOR ATRIAL FIBRILLATION WHEN and HOW

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Stand alone maze: when and how?

Catheter Ablation for Persistent Atrial Fibrillation

Management strategies for atrial fibrillation Thursday, 20 October :27

Interventional solutions for atrial fibrillation in patients with heart failure

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

In Whom and When Should Atrial Fibrillation Ablation be Considered?

Atrial Fibrillation Ablation: in Whom and How

Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

1995 Our First AF Ablation. Atrial Tachycardias During and After Atrial Fibrillation Ablation. Left Atrial Flutter. 13 Hours Later 9/25/2009

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation

Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary

Role of LAA isolation in AF cure

Basics of Atrial Fibrillation. By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY

Rate and Rhythm Control of Atrial Fibrillation

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Innovations in AF Management

Catheter ablation in AF patients with heart failure. What is possible?

Clinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

3/25/2017. Program Outline. Classification of Atrial Fibrillation

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It. Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN

Catheter ablation of AF Where do we stand, where do we go?

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond

ESSA HEART AND VASCULAR INSTITUTE APR/MAY/JUNE 2009 CLINICAL LETTER

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Ablazione della fibrillazione atriale: dubbi presenti e prospettive future

EHRA/EUROPACE 2011 Madrid, Spain June

Outcomes of AF Ablation

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

How does the heart work? The heart is muscle whose main function is a pump; to push blood the rest of your body.

Catheter Ablation of Atrial Fibrillation Persistent Atrial Fibrillation Catheter Ablation : where are we?

ABLATION OF CHRONIC AF

The HISTORIC-AF TRIAL

Ablation of long-standing AF. Is it wise to pursue it?

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Atrial Fibrillation: Interventional Approaches

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Controversies in Atrial Fibrillation and HF

Mission Statement for our Arrhythmia Care

UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate

Tachycardia-induced heart failure - Does it exist?

How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry

CLINICAL OUTCOME OF AF ABLATION Who Benefits from Catheter Ablation?? Dr Gamal Shaban MD FESC Fellow of EHRA ECR AFA AFIB ALLIANCE NHI

Supplementary Online Content

Catheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping -

High density substrate mapping In AF

Atrial Fibrillation Etiologies and Treatment. Shawn Liu Learner Centered Learning Goal

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

Ablation Update and Case Studies. Lawrence Nair, MD, FACC Director of Electrophysiology Presbyterian Heart Group

Ectopic Atrial Tachycardia

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation 2009

Atrial Fibrillation Management in the ED. J Fisher May 2014"

Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation

AF ablation Penn experience. Optimal approach to the ablation of PAF: Importance of identifying triggers 9/25/2009

APPROACH TO TACHYARRYTHMIAS

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist

PVI and What Else for Persistent AF Lessons Learned from STAR AF 2 CCCEP 2015 October 31, New York

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Hybrid approaches in atrial fibrillation ablation: why, where and who?

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO

Biatrial Maze or PVI to Ablate Afib? Marc Gillinov, MD

Surgical Ablation of Atrial Fibrillation. Gregory D. Rushing, MD. Assistant Professor, Division of Cardiac Surgery

Mapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria

Catheter Ablation of Atrial Fibrillation

480 April 2004 PACE, Vol. 27

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic

Atrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA

Atrial Fibrillation: Classification and Electrophysiology. Saverio Iacopino, MD, FACC, FESC

Atrial Fibrillation Procedures Data Summary. Participant STS Period Ending 12/31/2016

Transcription:

Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham

Atrial Fibrillation (AF) Affects 2% of the population Easily diagnosed 25% of 40 year olds will go on to suffer from AF Increases the risk of stroke 5x 20% of all strokes are due to AF

Symptoms from Atrial Fibrillation Irregular, often rapid ventricular rate Decreased cardiac output Symptoms of palpitations, fatigue, dyspnoea, dizziness and chest pain Loss of atrial contractility Decreased cardiac output Symptoms of fatigue and dyspnoea Risk of atrial thrombus formation and thromboembolism Death - AFib alone increases risk of death by 50-90% (Framingham)

Atrial fibrillation Paroxysmal Atrial fibrillation Self terminating (<7 days) Persistent Atrial Fibrillation Continuous > 7days or requires Cardioversion Long standing Persistent Atrial Fibrillation Continuous for > 1 year

What is important in AF management? 1.Prevent Strokes 2.Treat Symptoms

Traditional symptomatic treatments for Atrial fibrillation DC Cardioversion Pills Ablate and Pace

Cardioversion Cheap Easy to do High initial success rates (>90%) Not suitable for paroxysmal AFib Requires 1 month s anticoagulation before, and at least 3 months after

Cumulative mortality (%) Does rhythm control matter? 30 P=ns 25 20 15 10 Rhythm control Rate control 5 0 0 1 2 3 4 5 The AFFIRM Study N Engl J Med 2002; 347:1825-1833

Percent in Sinus Rhythm The problem with cardioversion? 100 90 80 70 60 Amiodarone Diltiazem Control 50 40 30 0 10 20 30 40 50 Long term success from cardioversion extremely poor Manios et al. Cardiovascular Drugs and Therapy 17 31 39 2003

Mechanisms of Atrial Fibrillation Keith & Flack, 1907 Cardioversion only resets the system Triggers: Pulmonary Vein SVC No effect on Triggers or Substrate Haissaguerre, NEJM, 1998 Normal Atrium Fibrosed atrium Substrate: Left atrial enlargement Fibrosis Rotors Electrical changes

Relative importance Paroxysmal AFib Long Standing Persistent AFib Triggers Substrate

The problem with drugs Amiodarone

The problem with drugs Sotalol Chong D W S et al. BMJ Case Reports 2009;2009:bcr.01.2009.1426

AFFIRM Revisited 47% Sinus rhythm is associated with reduced mortality The AFFIRM investigators. Circulation 2004;109:1509-1513

Does Rhythm control improve survival 47% 49% Sinus rhythm is associated with reduced mortality Antiarrythmic drugs are associated with increased mortality The AFFIRM investigators. Circulation 2004;109:1509-1513

When does Cardioversion work? 1 st Presentation When there is an acute trigger that has been reversed

AF is triggered from the pulmonary veins (90%) Electrical isolation of the pulmonary veins will stop Paroxysmal AF Haissaguerre et al NEJM 1999 A break through in Atrial fibrillation

How does it work? Ablation of Paroxysmal AF Keith & Flack, 1907 Cabrera, Circulation, 2002 Muscle sleeves in pulmonary veins act as triggers

Freedom from AF Ablation gives excellent symptom relief in paroxysmal AF? 100 80 60 Ablation Anti-arrhythmic drugs 40 20 Logrank p<0.0001 0 0 100 200 Follow-up (days) 300 The A4 Study Circulation. 2008;118:2498-2505.)

Maximum Workload (METS) Exercise Capacity 60 Mean SF-36 Mental Wellbeing Ablation (n=53) 55 10 Drug Treatment (n=59) 50 P<0.01 9 45 40 Baseline Day 91 Day 180 8 60 SF-36 Physical wellbeing 7 P<0.01 55 50 P<0.01 6 Baseline End of Study 45 40 Baseline Day 91 Day 180 Quality of Life

The Modern Approach Wide Area Circumferential Ablation

Catheter Ablation of Persistent AF Isolate triggers Pulmonary vein isolation (WACA) Ablate Substrate Lines Cavotricuspid isthmus Roof Mitral Isthmus Complex fractionated electrograms

Additional lesions for persistent AF- Roof line PA view (Carto Map) Superior view (NavX Map) Prevents re-entry between the pulmonary veins

Additional lesions for persistent AF- Mitral Isthmus line Prevents re-entry around the Mitral Isthmus

Mitral Isthmus Line Difficult to complete Mitral isthmus is thick Coronary sinus acts as a Heat sink Attack from both sides Mitral Isthmus Coronary Sinus Endocardial Epicardial

Additional lesions for persistent AF- CFAE ablation 58 ms 174 ms CFAE= Complex fractionated atrial electrograms ROTORS Areas of high frequency complex signals Act as Drivers for Atrial Fibrillation

CFAE mapping Atrial activity varies within the left atrium

Success ECG I II Left Atrial III Appendage avf Coronary V1 Sinus V6 Ablation Termination to sinus rhythm with ablation

Who should we ablate? SYMPTOMATIC AF Overall success rate? Often need more than one ablation Predictors of success?

Freedom from arrhythmia Does it work? The STAR AF study 100% p=0.03 80% 60% 40% p=0.14 Pulmonary vein isolation + CFAE Pulmonary vein isolation alone 20% 0% Paroxysmal Persistent AF Less than 1 year Success rate much better with modern techniques (CFAE) No difference between PAF and Persistent (<1 year)

Freedom from AF/AFl/Atach Does it work? The STAR AF study 100% p=0.001 80% 60% 40% AF ablation is very successful for patients with Continuous AF for less PVI + than CFE 1 year PVI 20% 0% 0 1 2 3 4 5 6 7 8 9 10 11 12 Months since last ablation Persistent Atrial Fibrillation after 2 procedures

Freedom from Recurrence (%) Ablation even works in Long Standing Persistent AF 100 90 80 70 60 50 40 30 20 10 0 Duration of Continuous AF < or = 21 months > 21 months P = 0.002 Hazard Ratio =0.13 0 5 10 15 20 25 30 Time since Procedure (months) Matsuo et al. J Am Coll Cardiol 2009;54:788

Are there any contraindications to ablation persistent AF Asymptomatic Very long standing continuous AF (>5 years) Some structural heart disease Hypertrophic cardiomyopathy Very large left atrium Unable to take warfarin IVC obstruction Some ASD repairs

Ablation is not risk free Fatal atrio-oesophageal fistula following AF ablation

Ablation Risks 1/1000 death 1/200 Stroke 3-5% major complication No known mortality benefit 50% patients need two procedure No evidence it removes the need for anticoagulation

Conclusion Cardioversion only indicated at first presentation or to assess symptoms Ablation is a extremely effective in symptomatic patients We can get excellent results even in less good patients May need multiple procedures